Copyright Reports & Markets. All rights reserved.

Global Cytomegalovirus Disease Treatments Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cytomegalovirus Disease Treatments Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ganciclovir
      • 1.4.3 Valganciclovir
      • 1.4.4 Foscarnet
      • 1.4.5 Cidofovir
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Cytomegalovirus Disease Treatments Market Share by Application (2014-2025)
      • 1.5.2 Stem Cell Transplantation
      • 1.5.3 Organ Transplantation
      • 1.5.4 Congenital CMV Infection
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cytomegalovirus Disease Treatments Market Size
    • 2.2 Cytomegalovirus Disease Treatments Growth Trends by Regions
      • 2.2.1 Cytomegalovirus Disease Treatments Market Size by Regions (2014-2025)
      • 2.2.2 Cytomegalovirus Disease Treatments Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cytomegalovirus Disease Treatments Market Size by Manufacturers
      • 3.1.1 Global Cytomegalovirus Disease Treatments Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cytomegalovirus Disease Treatments Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cytomegalovirus Disease Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cytomegalovirus Disease Treatments Key Players Head office and Area Served
    • 3.3 Key Players Cytomegalovirus Disease Treatments Product/Solution/Service
    • 3.4 Date of Enter into Cytomegalovirus Disease Treatments Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cytomegalovirus Disease Treatments Market Size by Type (2014-2019)
    • 4.2 Global Cytomegalovirus Disease Treatments Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 5.2 Cytomegalovirus Disease Treatments Key Players in United States
    • 5.3 United States Cytomegalovirus Disease Treatments Market Size by Type
    • 5.4 United States Cytomegalovirus Disease Treatments Market Size by Application

    6 Europe

    • 6.1 Europe Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 6.2 Cytomegalovirus Disease Treatments Key Players in Europe
    • 6.3 Europe Cytomegalovirus Disease Treatments Market Size by Type
    • 6.4 Europe Cytomegalovirus Disease Treatments Market Size by Application

    7 China

    • 7.1 China Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 7.2 Cytomegalovirus Disease Treatments Key Players in China
    • 7.3 China Cytomegalovirus Disease Treatments Market Size by Type
    • 7.4 China Cytomegalovirus Disease Treatments Market Size by Application

    8 Japan

    • 8.1 Japan Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 8.2 Cytomegalovirus Disease Treatments Key Players in Japan
    • 8.3 Japan Cytomegalovirus Disease Treatments Market Size by Type
    • 8.4 Japan Cytomegalovirus Disease Treatments Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 9.2 Cytomegalovirus Disease Treatments Key Players in Southeast Asia
    • 9.3 Southeast Asia Cytomegalovirus Disease Treatments Market Size by Type
    • 9.4 Southeast Asia Cytomegalovirus Disease Treatments Market Size by Application

    10 India

    • 10.1 India Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 10.2 Cytomegalovirus Disease Treatments Key Players in India
    • 10.3 India Cytomegalovirus Disease Treatments Market Size by Type
    • 10.4 India Cytomegalovirus Disease Treatments Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cytomegalovirus Disease Treatments Market Size (2014-2019)
    • 11.2 Cytomegalovirus Disease Treatments Key Players in Central & South America
    • 11.3 Central & South America Cytomegalovirus Disease Treatments Market Size by Type
    • 11.4 Central & South America Cytomegalovirus Disease Treatments Market Size by Application

    12 International Players Profiles

    • 12.1 Merck
      • 12.1.1 Merck Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cytomegalovirus Disease Treatments Introduction
      • 12.1.4 Merck Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.1.5 Merck Recent Development
    • 12.2 Chimerix
      • 12.2.1 Chimerix Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cytomegalovirus Disease Treatments Introduction
      • 12.2.4 Chimerix Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.2.5 Chimerix Recent Development
    • 12.3 Abbott
      • 12.3.1 Abbott Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cytomegalovirus Disease Treatments Introduction
      • 12.3.4 Abbott Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.3.5 Abbott Recent Development
    • 12.4 Bio-Rad
      • 12.4.1 Bio-Rad Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cytomegalovirus Disease Treatments Introduction
      • 12.4.4 Bio-Rad Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.4.5 Bio-Rad Recent Development
    • 12.5 Roche
      • 12.5.1 Roche Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cytomegalovirus Disease Treatments Introduction
      • 12.5.4 Roche Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.5.5 Roche Recent Development
    • 12.6 Gilead Sciences
      • 12.6.1 Gilead Sciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cytomegalovirus Disease Treatments Introduction
      • 12.6.4 Gilead Sciences Revenue in Cytomegalovirus Disease Treatments Business (2014-2019)
      • 12.6.5 Gilead Sciences Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body.
      In 2018, the global Cytomegalovirus Disease Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cytomegalovirus Disease Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cytomegalovirus Disease Treatments development in United States, Europe and China.

      The key players covered in this study
      Merck
      Chimerix
      Abbott
      Bio-Rad
      Roche
      Gilead Sciences
      ...

      Market segment by Type, the product can be split into
      Ganciclovir
      Valganciclovir
      Foscarnet
      Cidofovir
      Others

      Market segment by Application, split into
      Stem Cell Transplantation
      Organ Transplantation
      Congenital CMV Infection
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cytomegalovirus Disease Treatments status, future forecast, growth opportunity, key market and key players.
      To present the Cytomegalovirus Disease Treatments development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cytomegalovirus Disease Treatments are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now